Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours Β· Estimated delivery Sep 1 - Sep 6
Semaglutide, a GLP-1 agonist, primarily aims to improve glycemic control for those managing type 2 diabetes and obesity
Maxler , , - (L-Carnitine 3000), 3000 25
Tirzepatide Introduced in 2022 under the brand name Mounjaro, Tirzepatide is a medication that combines the effects of GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 receptor agonists
Both medications treat obesity and many related metabolic conditions, Isaacs said
Serious & unknown risks Not established The Phase 2 trials didn't turn up an unexpected serious safety signal, but they were short
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
